COVID-19 in Pediatric Patients: clinical and immunological features
- Conditions
- COVID-19 in childrenmulti-system inflammatory in children (MIS-C)1002766510047438
- Registration Number
- NL-OMON54119
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 200
- age up to and including 17 years
- clinical or microbiological diagnosis of COVID-19 or MIS-C
- presentation in hospital (outpatient department, emergency department, or
clinical admission)
Study population of the substudy on reinfections: enrolled participants of the
initial studies COPP/COPP-IMM will be approached to also participate in the
current substudy.
Inclusion criteria for this substudy:
- Children with a prior COVID-19 infection and/or MIS-C, treated as in- or
outpatients in Dutch hospitals, AND
- Previously included in the COPP/COPP-IMM study between 1st of March 2020 and
1st of September 2022, with consent to be approached for subsequent studies, AND
- Informed consent for the reinfection substudy
Age 18 years or older
No COVID-19 or MIS-C
No informed consent
For blood sampling: body weight under 3 kg
Exclusion criteria for the substudy on reinfections
A potential subject who meets any of the following criteria will be excluded
from
- No consent from guardians and/or patient
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method